OppenheimerFunds’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$408K Sell
17,396
-2,248
-11% -$56.9K ﹤0.01% 1441
2018
Q4
$399K Buy
19,644
+7,556
+63% +$206K ﹤0.01% 1460
2018
Q3
$521K Buy
12,088
+1,251
+12% +$54K ﹤0.01% 1430
2018
Q2
$473K Buy
10,837
+1,977
+22% +$86.5K ﹤0.01% 1449
2018
Q1
$427K Sell
8,860
-107
-1% -$5.14K ﹤0.01% 1467
2017
Q4
$455K Buy
8,967
+400
+5% +$21.9K ﹤0.01% 1550
2017
Q3
$491K Sell
8,567
-124
-1% -$6.19K ﹤0.01% 1529
2017
Q2
$450K Buy
8,691
+272
+3% +$14K ﹤0.01% 1555
2017
Q1
$452K Buy
8,419
+2,861
+51% +$162K ﹤0.01% 1537
2016
Q4
$344K Buy
5,558
+438
+9% +$24.2K ﹤0.01% 1545
2016
Q3
$262K Sell
5,120
-1,340
-21% -$62.8K ﹤0.01% 1549
2016
Q2
$249K Sell
6,460
-761
-11% -$28.1K ﹤0.01% 1538
2016
Q1
$235K Sell
7,221
-871
-11% -$25.6K ﹤0.01% 1546
2015
Q4
$287K Buy
+8,092
New +$277K ﹤0.01% 1527

Other funds holding LDL

OppenheimerFunds's LDL Position: Q1 2019 in Review

OppenheimerFunds reduced its Lydall, Inc. (LDL) stake by 11% in Q1 2019, selling an estimated $56.9K and leaving 17,396 shares worth $408K. The position accounts for ﹤0.01% of the portfolio, ranked #1441.

OppenheimerFunds first reported a position in LDL in Q4 2015 and has held it in 14 quarters since. The position peaked at $521K in Q3 2018. 134 funds tracked by Wall St. Rank hold LDL as of Q1 2019.

  • OppenheimerFunds held 17,396 shares of Lydall, Inc. worth $408K as of Q1 2019.
  • OppenheimerFunds sold 2,248 Lydall, Inc. shares in Q1 2019, an estimated $56.9K.
  • Lydall, Inc. made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1441 holding.
  • OppenheimerFunds first reported a position in Lydall, Inc. in Q4 2015 and has held it in 14 quarters since.
  • OppenheimerFunds's Lydall, Inc. position peaked at $521K in Q3 2018.
  • 134 funds tracked by Wall St. Rank held Lydall, Inc. as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.